Scientific Program
The CHEST Congress 2021 online event scientific program is created in collaboration with the CHEST Italian Delegation and will incorporate the best of CHEST Annual Meeting, including lectures, recent advancements in clinical practice and science. The presenting speakers will feature some of the best minds in chest medicine from around the world.
All times in the program are in CET time zone (GMT+2)
*Please note the program is subject to change
17 June, 2021
Welcome From CHEST President
Speaker: Steven Q. Simpson, MD, FCCP
Welcome
Speakers:
William F. Kelly, MD, FCCP
Francesco de Blasio, MD, FCCP
Girolamo Pelaia, MD, FCCP
COVID Panel
Speakers:
Stefano Nava, MD
Semra Bilaceroglu, MD
Mangala Narasimhan, DO, FCCP
Dr. Nava will describe the differences between the first and other
waves in Italy and discuss what we have changed in our practice during the last year. We will also remember all the nurses and doctors who lost their lives on service.
Dr. Narasimhan will review state-of-the-art treatment. The session will also address worldwide issues and trends. Attendees will get a global perspective. Come watch the panel!
Dr. Bilaceroglu will be talking on Global Impact of COVID-19 on Respiratory Diseases.
It will be a comprehensive review covering the implications and impact of COVID-19 on respiratory diseases regarding diagnostic, therapeutic, prognostic aspects.
Game 1
Moderator: William F. Kelly, MD, FCCP
Non-CME Industry Session organized by: MSD
(not included in the main event CME/CPD credit offering)
Speaker: Mario Cazzola, MD
Speaker: Fabien Maldonado, MD, FCCP
Come and review the practice-changing pleural disease papers you wanted to read but didn’t get a chance to! We will discuss malignant pleural effusions, pneumothorax, and pleural space infections.
Speaker: Richard Casaburi, MD, PhD, FCCP
The best
development is the recent demonstration that pulmonary rehabilitation, delivered after a hospitalization for COPD exacerbation, substantially improves survival. Rehabilitation therefore joins a very small number of interventions demonstrated to improve COPD mortality.
The worst
development is the tragically low availability of pulmonary rehabilitation, made even worse by the pandemic. Whether attempts to institute home rehabilitation programs will be of help will be discussed.
Global Consult Sessions
Case presentations. Please note the cases are divided in rooms, based on topic:
- Challenging Airway Stent Cases
- COVID prognostic markers
- Unusual Pulmonary Cases
- Post-COVID infections
- PET positive thoracic lesions – is it cancer?
- ECMO and Seraph filters
24 June, 2021
Welcome From CHEST Past President
Speaker: Stephanie M. Levine, MD, FCCP
Speaker: Stefano Aliberti, MD
Speaker: Sumita B. Khatri, MD, FCCP
Asthma is prevalent worldwide, and can emerge from various exposures and risk factors throughout a lifetime. Understanding the phenotypes and endotypes of asthma is necessary to provide state-of-the-art care for individuals with asthma. However, models of care may vary based upon access to advanced levels of care and latest therapies, including biologic therapies. In our session we will explore best practices within the ideal state and the real-world experience of asthma care by examining various models of care in the context of guidelines set worldwide.
Speaker: Javier Flandes, MD, PhD, FCCP
Explore how the combination of navigation bronchoscopy and fluoroscopy using novel integration software can improve diagnostic yield in lung peripheral nodules. Discuss how fluoroscopy adds certainty about the situation of catheter and different tools related to the lesion.
Game 2
Moderator: William F. Kelly, MD, FCCP
Speaker: Steven D. Nathan, MBBCh, FCCP
Group 3 pulmonary hypertension has always presented a clinical conundrum.
Do we look for it or not? And if we find it, what to do? To treat or not to treat? Emerging evidence suggests that this is a viable target with new evidence resulting in the FDA’s approval of the first agent targeting PH-ILD.
Speaker: Victor J. Test, MD, FCCP
This session will explore methods for clinical assessment and risk stratification of patients with pulmonary arterial hypertension. We will look at clinical, laboratory and scoring systems.
Escape Room
Moderator: William F. Kelly, MD, FCCP
In a future world battered by a pandemic, economic travails, and 24/7 zoom meetings, you and 5 peers must race toward Jupiter. Buckle up, mask up, and engage! Bring your thinking cap, as you and your team will have to exercise your knowledge and problem-solving skills on medical knowledge-based puzzles. Come jump into this hyperspace adventure of a lifetime! What could possibly go wrong?
While exercising your knowledge in the CHEST Escape Room, learn about the CHEST Foundation, our work in antiracism and health disparities, and how you can help support our efforts!